SCHEMBL26192

SCHEMBL26192

O=CNN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27501865 0.97 — —
SCHEMBL4425977 0.97 ADH1B (0.31) —
Ammonia Solution, Strong SCHEMBL28206563 0.94 — —
Hydrochloric Acid SCHEMBL14795062 0.94 — —
SCHEMBL1259819 0.94 — —
SCHEMBL6050116 0.87 — —
SCHEMBL28206601 0.83 ADH1B (0.33) —
SCHEMBL10903267 0.80 ADH1B (0.31) —
SCHEMBL5525441 0.78 CXCR4 (0.32) —
SCHEMBL18298064 0.76 HTT (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 860 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114981281-A Method for producing oligonucleotide compound 日本新药株式会社 2022-08-30 — — CN claimed
CN-114981280-A Method for producing oligonucleotide compound 日本新药株式会社 2022-08-30 — — CN claimed
EP-3972590-A1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES Merck Sharp & Dohme Corp. (US) 2022-03-30 — — EP claimed
WO-2021095874-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND 日本新薬株式会社 2021-05-20 — — WO claimed
WO-2021095875-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND 日本新薬株式会社 2021-05-20 — — WO claimed
WO-2020236688-A1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES MERCK SHARP & DOHME CORP. (US) 2020-11-26 — — WO claimed
CN-110498768-A Heptan piperazine class compound and its preparation antipsychotic drug in application SHANGHAI ZHONGZE MEDICINE TECH CO LTD 2019-11-26 — — CN claimed
CN-110139852-A Tricyclic heterocyclic derivatives and use thereof 奥克兰联合服务有限公司 2019-08-16 — — CN claimed
CN-109952301-A 5-HT2C receptor agonists and compositions and methods of use 艾尼纳制药公司 2019-06-28 — — CN claimed
CN-109535164-A JAK kinase inhibitor, preparation method thereof and application thereof in medical field 上海华汇拓医药科技有限公司 2019-03-29 — — CN claimed
US-5935981-A INSECTICIDAL/MITICIDAL ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-08-10 — — US claimed
US-5849768-A α-unsaturated amines, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-12-15 — — US claimed
EP-0529680-B1 Intermediates, their production and their use for preparing alpha-unsaturated amines TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-05-13 — — EP claimed
EP-0770079-A1 HETEROBICYCLIC DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-02 — — EP claimed
EP-0302389-B1 Alpha-unsaturated amines, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1993-12-22 — — EP claimed
EP-0529680-A2 Intermediates, their production and their use for preparing alpha-unsaturated amines TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-03-03 — — EP claimed
EP-0279239-B1 MICROBICIDES CIBA-GEIGY AG (CH) 1992-11-11 — — EP claimed
US-5021434-A Aromatase inhibitors SCHERING AKTIENGESELLSCHAFT (DE) 1991-06-04 — — US claimed
EP-0279239-A1 Microbicides CIBA-GEIGY AG (CH) 1988-08-24 — — EP claimed
US-4650868-A 7-deazapurine derivatives useful as antitumor agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-03-17 — — US claimed
Send feedback